Table 4 |
||||||
|
WOMAC pain scores by group and visit |
||||||
|
Group |
||||||
|
UP446 250 mg/day |
UP446 500 mg/day |
Celecoxib 200 mg/day |
Placebo |
|||
|
|
||||||
|
Visit |
Baseline |
Mean |
3.17 |
3.41 |
3.20 |
2.97 |
|
Std Deviation |
0.80 |
0.93 |
0.89 |
0.60 |
||
|
30 Days |
Mean |
2.65 |
2.44 |
3.00 |
2.67 |
|
|
Std Deviation |
0.77 |
0.92 |
0.92 |
0.62 |
||
|
60 Days |
Mean |
2.63 |
2.63 |
2.20 |
3.29 |
|
|
Std Deviation |
0.66 |
0.79 |
0.66 |
0.67 |
||
|
90 Days |
Mean |
2.67 |
2.11 |
2.27 |
3.00 |
|
|
Std Deviation |
0.65 |
0.86 |
0.66 |
0.58 |
||
|
|
||||||
|
Sampalis and Brownell Nutrition Journal 2012 11:21 doi:10.1186/1475-2891-11-21 |
||||||
